Arabic Arabic English English French French German German
dark

Stakeholder Call: COVID-19 Vaccine Update – 4/27/2021

Acting FDA Commissioner Janet Woodcock, M.D. and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., discuss the Johnson & Johnson (Janssen) COVID-19 Vaccine.

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

HUB to transform national transactional insurance strategy

Next Post

Did we miss the boat with pandemic preparedness?

Related Posts
Total
0
Share